Aspire Biopharma Holdings, Inc. (ASBP) earnings
Quarterly results of Aspire Biopharma Holdings, Inc. as filed with the SEC: revenue, net income and earnings per share for each of the last 8 quarters, the latest results release and when the next one is expected.
Next earnings date
Aspire Biopharma Holdings, Inc. was expected to report around November 11, 2026; nothing is on file with the SEC yet.
Latest quarter: Q2 FY2026
In Q2 FY2026 (ended June 30, 2026) Aspire Biopharma Holdings, Inc. reported revenue of $63.1K and a net loss of $1.3M.
Diluted earnings per share were -$1.22.
Quarter by quarter
| Quarter | Revenue | vs year ago | Net income | EPS |
|---|---|---|---|---|
| Q2 FY2026 | $63.1K | - | -$1.3M | -$1.22 |
| Q1 FY2026 | $28.4K | - | -$3.2M | -$20.57 |
| Q4 FY2025 | - | - | -$4.7M | - |
| Q3 FY2025 | $1.9K | - | -$1.9M | -$0.04 |
| Q2 FY2025 | - | - | -$2M | -$48.19 |
| Q1 FY2025 | - | - | -$15.9M | -$504.88 |
| Q4 FY2024 | - | - | -$765.7K | - |
| Q3 FY2024 | - | - | -$216.3K | -$0.01 |
Results filings
- Quarterly report 10-Q
- Quarterly report 10-Q
When is Aspire Biopharma Holdings, Inc.'s next earnings date?
Aspire Biopharma Holdings, Inc. was expected to report around November 11, 2026; nothing is on file with the SEC yet.
What were Aspire Biopharma Holdings, Inc.'s latest quarterly results?
For Q2 FY2026, which ended June 30, 2026, Aspire Biopharma Holdings, Inc. reported revenue of $63.1K and a net loss of $1.3M. The figures come from its filing with the SEC.
Get an email when ASBP reports
Follow ASBP and we email you its next results the day they are filed, with the numbers explained.